BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34865381)

  • 1. [Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].
    Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
    Zhonghua Nei Ke Za Zhi; 2020 Aug; 59(8):629-633. PubMed ID: 34865381
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application and clinical study of clonal heterogeneity analysis in acute myeloid leukemia].
    Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):483-489. PubMed ID: 32654462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].
    Zheng YZ; Zheng H; Chen ZS; Hua XL; Le SH; Li J; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):19-25. PubMed ID: 35231988
    [No Abstract]   [Full Text] [Related]  

  • 4. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
    Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
    J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
    Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical Study on the Relationship between Gene Mutation Profile and Prognosis in Pediatric Acute Lymphocyte Leukemia].
    Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
    Baldus CD; Thibaut J; Goekbuget N; Stroux A; Schlee C; Mossner M; Burmeister T; Schwartz S; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
    Haematologica; 2009 Oct; 94(10):1383-90. PubMed ID: 19794083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 10. The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.
    Shen Z; Chu XL; Wang RX; Li JL; Liu MY; Xie YY; Wang C; Han R; Yu JQ; Wang J; Tao T; Shen HJ; Chen SN; Wu DP; Qiu QC; Liu SB; Xue SL
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e259-e269. PubMed ID: 32173273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
    Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
    J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.
    Fries C; Adlowitz DG; Spence JM; Spence JP; Rock PJ; Burack WR
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28280. PubMed ID: 32277801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
    Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
    Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
    de Smith AJ; Ojha J; Francis SS; Sanders E; Endicott AA; Hansen HM; Smirnov I; Termuhlen AM; Walsh KM; Metayer C; Wiemels JL
    Oncotarget; 2016 Nov; 7(45):72733-72745. PubMed ID: 27683039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.